{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-12T12:19:50.931319+00:00",
  "news": [
    {
      "title": "With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPQ2N4Z1kwbkphSUhyQWFDWXhqd0lld2dUd3FYWFNLRzZIaGk1SHZsdGM0QVBwQXQ2cHRKOXRrNGhJQzM4SG9PR0Jjbk9jNFBsYjh5QnhtSnZmUWJxTWdXVWE5SWtnbFRtZmhGYllBOTJNeWVGbkU1MXBoUmdxTFRONQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxPQ2N4Z1kwbkphSUhyQWFDWXhqd0lld2dUd3FYWFNLRzZIaGk1SHZsdGM0QVBwQXQ2cHRKOXRrNGhJQzM4SG9PR0Jjbk9jNFBsYjh5QnhtSnZmUWJxTWdXVWE5SWtnbFRtZmhGYllBOTJNeWVGbkU1MXBoUmdxTFRONQ?oc=5\" target=\"_blank\">With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-12T11:00:17+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-12T08:24:26+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWUxadWVlZVEwQkhyTXlTcDA4NXpyY3lQeWVlcUdvV20xR1dsUzlHS3Z3VXVqSERDTUh5cXNuSm1UTnZyclI2WUtVZEZCNXlmM2ZKOEcyVHFkZWp1MzV2V010S05ub3Zod0hGNy1heW85cFBJTFZybTYxeXJocmg2U25GVDhpbldnLVpyUHFlTHY1R2p2TlZtaUZOSnhwSlR1TWVjVTF0bHlpYzRGR1BFUTcxYlVrNHBsMnFodW1DenF6QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWUxadWVlZVEwQkhyTXlTcDA4NXpyY3lQeWVlcUdvV20xR1dsUzlHS3Z3VXVqSERDTUh5cXNuSm1UTnZyclI2WUtVZEZCNXlmM2ZKOEcyVHFkZWp1MzV2V010S05ub3Zod0hGNy1heW85cFBJTFZybTYxeXJocmg2U25GVDhpbldnLVpyUHFlTHY1R2p2TlZtaUZOSnhwSlR1TWVjVTF0bHlpYzRGR1BFUTcxYlVrNHBsMnFodW1DenF6QQ?oc=5\" target=\"_blank\">Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-12T11:00:00+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms - The American Journal of Managed Care® (AJMC®)",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5\" target=\"_blank\">Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The American Journal of Managed Care® (AJMC®)</font>",
      "published": "2025-10-06T21:09:24+00:00",
      "source": "The American Journal of Managed Care® (AJMC®)"
    },
    {
      "title": "Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers - CNBC",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5\" target=\"_blank\">Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-10-07T19:31:48+00:00",
      "source": "CNBC"
    },
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-07T00:50:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5\" target=\"_blank\">Amgen to sell cholesterol drug at 60% discount to cash-paying US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-06T16:38:50+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen unveils DTC platform with 60% discount on Repatha, giving US lowest price of G7 nations - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUWgybXNXRktwaFc0VUdsMVhRSjVLbjgwOHpGNl9aNDZpb0RIRTZneGlyVXFSaVlkS1hOQ2tueFRZelZqN29XeGtFU0NlYy1aaFVzZkRMQ0xLMHZHWlJ0bEF5dGVyRkNmU1JoekRiXzJpZ2pHS2VpQUZJMnFhdVdKRUJCbWdZUXN3UTBGNGs5RFY3QXlFb2k2ZDY4cHRRTmpxMlNJRlV3b0pJOEpWVEFSYTl4QzRQUlQzWmZj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUWgybXNXRktwaFc0VUdsMVhRSjVLbjgwOHpGNl9aNDZpb0RIRTZneGlyVXFSaVlkS1hOQ2tueFRZelZqN29XeGtFU0NlYy1aaFVzZkRMQ0xLMHZHWlJ0bEF5dGVyRkNmU1JoekRiXzJpZ2pHS2VpQUZJMnFhdVdKRUJCbWdZUXN3UTBGNGs5RFY3QXlFb2k2ZDY4cHRRTmpxMlNJRlV3b0pJOEpWVEFSYTl4QzRQUlQzWmZj?oc=5\" target=\"_blank\">Amgen unveils DTC platform with 60% discount on Repatha, giving US lowest price of G7 nations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-10-06T15:01:55+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-10",
      "close": 290.1300048828125
    },
    "history": [
      {
        "date": "2025-10-02",
        "close": 297.3999938964844
      },
      {
        "date": "2025-10-03",
        "close": 297.8900146484375
      },
      {
        "date": "2025-10-06",
        "close": 294.1199951171875
      },
      {
        "date": "2025-10-07",
        "close": 295.5400085449219
      },
      {
        "date": "2025-10-08",
        "close": 294.6199951171875
      },
      {
        "date": "2025-10-09",
        "close": 295.42999267578125
      },
      {
        "date": "2025-10-10",
        "close": 290.1300048828125
      }
    ],
    "name": "Amgen Inc."
  }
}